"Insurance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency.
| Descriptor ID |
D007341
|
| MeSH Number(s) |
N03.219.521.576
|
| Concept/Terms |
Insurance Premiums- Insurance Premiums
- Insurance Premium
- Premium, Insurance
- Premiums, Insurance
|
Below are MeSH descriptors whose meaning is more general than "Insurance".
Below are MeSH descriptors whose meaning is more specific than "Insurance".
This graph shows the total number of publications written about "Insurance" by people in this website by year, and whether "Insurance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance" by people in Profiles.
-
Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer. Ann Surg Oncol. 2023 Jun; 30(6):3560-3568.
-
Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 06 01; 77(6):E176-E177.
-
Insurance lesions: Does a second lesion make a difference? J Cardiovasc Electrophysiol. 2022 07; 33(7):1507-1512.
-
The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States. Blood Adv. 2022 03 08; 6(5):1566-1576.
-
The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ. 2022 Jan-Dec; 25(1):650-659.
-
Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns. Cancer Med. 2020 07; 9(14):5281-5290.
-
The Roles Of Assisters And Automated Decision Support Tools In Consumers' Marketplace Choices: Room For Improvement. Health Aff (Millwood). 2019 03; 38(3):473-481.
-
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol. 2017 12 01; 2(12):1369-1374.
-
Refinement of the Affordable Care Act. Annu Rev Med. 2018 01 29; 69:19-28.
-
Data monitoring committees: Promoting best practices to address emerging challenges. Clin Trials. 2017 Apr; 14(2):115-123.